![]() |
市场调查报告书
商品编码
1755848
2032 年口含烟市场预测:按产品类型、强度、口味、分销管道、人口统计、应用和地区进行的全球分析Snus Market Forecasts to 2032 - Global Analysis By Product Type (Loose Snus, Portion Snus, and Other Product Types), Strength, Flavor, Distribution Channel, Demographics, Application and By Geography |
根据 Stratistics MRC 的数据,全球口含烟市场预计在 2025 年达到 34.2 亿美元,到 2032 年将达到 53.9 亿美元,预测期内的复合年增长率为 6.7%。
鼻烟是一种传统上在瑞典和挪威使用的湿润无烟烟草产品。它被放置在上唇下方,无需吐出,使其成为一种隐藏的吸烟替代品。鼻烟有散装或预先包装的小袋装两种形式,无需燃烧即可释放尼古丁。它通常带有调味剂,既能吸引传统用户,也能吸引寻求烟草替代品的现代消费者。不同国家对口含烟的监管有所不同,但有些市场允许合法销售。
根据挪威统计局发布的「烟草、酒精和其他药物」数据,2021年,16至74岁人口中有15%的人报告每天使用口含烟,比2020年略有增加2个百分点。
无烟烟草产品需求不断成长
人们对吸烟相关健康风险的认识不断提高,推动了对无烟烟草替代品的需求。消费者对低风险产品的渴望,推动了全球口含烟市场的成长。公共场所吸烟限制进一步推动了无烟烟草的普及。此外,社会对适度烟草消费的接受度不断提高,也推动了市场扩张。因此,製造商正致力于扩大产品供应,以满足不断变化的偏好。
与尼古丁袋装电子烟和电子烟的竞争
由于尼古丁袋装电子烟不含烟草成分且被认为健康风险较低,消费者越来越多地选择尼古丁袋装电子烟。电子烟产品凭藉其可自订的口味和最新技术的融合,持续吸引着用户。监管政策倾向于支持尼古丁替代品而非传统烟草产品,这进一步影响了口含烟的销售。此外,尼古丁袋装电子烟和电子烟製造商的积极行销宣传活动也影响着消费者的选择。这种竞争格局对寻求维持市场占有率的口含烟製造商构成了挑战。
转向减害产品
各国政府和卫生组织正在推广无烟烟草替代品,以最大限度地减少吸烟相关疾病的影响。研发投入的不断增加,使得产品配方得到改进,健康风险也随之降低。包括有机和无添加剂在内的创新鼻烟品种的推出,对注重健康的消费者颇具吸引力。对尼古丁成瘾性较低的烟草产品的需求不断增长,也推动了市场的成长。随着人们对减少危害的日益关注,预计口含烟行业将受益于有利的消费趋势。
健康问题和警告
警告标籤和公共卫生宣传活动提高了人们的意识,却阻碍了潜在消费者的消费,并限制了市场扩张。此外,尤其是在欧盟等地区,严格的行销和包装法规进一步限制了该行业的运作。口含烟作为危害较小的吸烟替代品的观念也受到了质疑,新的研究对其安全性提出了质疑。所有这些因素都降低了消费者信心,对市场的成长潜力构成了重大挑战。
COVID-19的影响
由于消费者购买行为的变化和供应链中断,新冠疫情对口含烟市场产生了重大影响。封锁和限制措施暂时减少了包括鼻烟在内的烟草製品的销售量。然而,网路购物和电子商务的普及有助于维持市场需求。疫情提高了人们对呼吸健康的认识,导致一些使用者转向无烟烟草替代品。疫情过后,製造商正致力于透过线上分销管道提高可及性。
预计 Ruth 鼻烟将成为预测期内最大的
预计散装鼻烟市场将在预测期内占据最大市场占有率,这得益于其在长期用户中的传统吸引力。散装鼻烟允许使用者客製化份量,使其成为经验丰富的消费者的首选。高品质、浓郁烟草口味的散装鼻烟的供应进一步推动了市场需求。此外,某些地区对散装鼻烟的文化偏好也促进了市场持续成长。
预计预测期内调味口含烟市场将以最高复合年增长率成长
预计在预测期内,调味口含烟细分市场将实现最高成长率。薄荷、莓果和柑橘类等口味的鼻烟品种对老用户和新用户都极具吸引力。越来越多的异国风味和创新配方正在吸引更年轻的消费群体。此外,无糖和天然成分调味口含烟产品的推出也正在扩大市场。
由于消费者意识的提升和烟草消费的增长,预计亚太地区将在预测期内占据最大的市场占有率。无烟烟草替代品的接受度不断提高,尤其是在吸烟法规严格的国家,正在推动市场成长。可支配所得水准的提高和都市化正在影响购买模式。政府支持烟草减害策略的措施正在推动口含烟的普及。
由于消费行为健康意识的增强以及监管变化,预计北美将在预测期内实现最高的复合年增长率。低风险烟草产品的需求激增,推动了口含烟市场的扩张。消费者对减害策略的认识不断提高,也推动了鼻烟的采用率。知名製造商对产品创新的投资也推动了鼻烟市场的成长。
According to Stratistics MRC, the Global Snus Market is accounted for $3.42 billion in 2025 and is expected to reach $5.39 billion by 2032 growing at a CAGR of 6.7% during the forecast period. Snus is a moist, smokeless tobacco product traditionally used in Sweden and Norway. It is placed under the upper lip and does not require spitting, making it a discreet alternative to smoking. Available in loose or portioned pouches, snus delivers nicotine without combustion. Often flavored, it appeals to both traditional users and modern consumers seeking tobacco alternatives. Snus is regulated differently across countries, with legal sales permitted in select markets.
According to data published by Statistics Norway on 'Tobacco, alcohol, and other drugs,' in 2021, 15 percent of individuals aged 16 to 74 reported using snus daily, marking a slight increase of 2 percentage points since 2020.
Increasing demand for smokeless tobacco products
The rising awareness about the health risks associated with smoking has led to an increasing demand for smokeless tobacco alternatives. Consumers are seeking reduced-risk products, contributing to the growth of snus in global markets. Regulatory restrictions on smoking in public places are further driving the adoption of smokeless tobacco. Additionally, growing social acceptance of discreet tobacco consumption is fueling market expansion. As a result, manufacturers are focusing on expanding their product offerings to meet evolving preferences.
Competition from nicotine pouches & vapes
Consumers are increasingly opting for nicotine pouches due to their tobacco-free composition and perceived lower health risks. Vaping products continue to attract users with customizable flavors and modern technology integration. Regulatory policies favoring nicotine alternatives over traditional tobacco products are further impacting snus sales. Additionally, aggressive marketing campaigns by nicotine pouch and vape manufacturers are influencing consumer choices. This competitive landscape presents challenges for snus manufacturers aiming to maintain market share.
Shift toward harm reduction products
Governments and health organizations are promoting smokeless tobacco alternatives to minimize the impact of smoking-related diseases. Increasing investment in research and development is leading to improved product formulations with reduced health risks. The introduction of innovative snus varieties, including organic and additive-free options, is appealing to health-conscious consumers. Rising demand for tobacco products with lower nicotine dependency is driving market growth. As the focus on harm reduction intensifies, the snus industry is expected to benefit from favorable consumer trends.
Health concerns & warnings
Warning labels and public health campaigns have raised awareness, deterring potential consumers and limiting market expansion. Additionally, stringent regulations on marketing and packaging, especially in regions like the EU, further constrain industry operations. The perception of snus as a less harmful alternative to smoking is also under scrutiny, as emerging studies challenge its safety. These factors collectively reduce consumer trust and pose major challenges to the market's growth potential.
Covid-19 Impact
The COVID-19 pandemic significantly impacted the snus market due to changes in consumer purchasing behavior and supply chain disruptions. Lockdowns and restrictions led to a temporary decline in tobacco product sales, including snus. However, increased online shopping and e-commerce adoption helped sustain market demand. The pandemic heightened awareness of respiratory health, leading some users to shift toward smokeless tobacco alternatives. Post-pandemic, manufacturers are focusing on enhancing accessibility through online distribution channels.
The loose snus segment is expected to be the largest during the forecast period
The loose snus segment is expected to account for the largest market share during the forecast period, due to its traditional appeal among long-time users. Loose snus allows users to customize their portion size, making it a preferred choice for experienced consumers. The availability of high-quality variants with rich tobacco flavors is further driving market demand. Additionally, cultural preferences for loose snus in certain regions contribute to sustained growth.
The flavored snus segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the flavored snus segment is predicted to witness the highest growth rate, due to rising consumer preference for enhanced taste experiences. Flavored snus varieties, including mint, berry, and citrus, appeal to both seasoned and new users. The increasing availability of exotic flavors and innovative blends is attracting younger demographics. Additionally, the introduction of sugar-free and natural ingredient-based flavored snus products is expanding market reach.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising consumer awareness and expanding tobacco consumption. The growing acceptance of smokeless tobacco alternatives, particularly in countries with strict smoking regulations, is driving market growth. Increasing disposable income levels and urbanization are influencing purchasing patterns. Government initiatives supporting tobacco harm reduction strategies are promoting snus adoption.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to increasing health-conscious consumer behavior and regulatory shifts. The demand for reduced-risk tobacco products is growing rapidly, driving snus market expansion. Rising awareness regarding harm reduction strategies among consumers is boosting adoption rates. The presence of prominent manufacturers investing in product innovation is accelerating growth.
Key players in the market
Some of the key players profiled in the Snus Market include Swedish Match AB, British American Tobacco (BAT), Altria Group Inc., Philip Morris International (PMI), Imperial Brands plc, GN Tobacco Sweden AB, Japan Tobacco International (JTI), Skruf Snus AB, Another Snus Factory, Dholakia Tobacco Pvt. Ltd., Mac Baren Tobacco Company A/S, Ministry of Snus, Nordic Snus AB, Kurbits Snus AB, and Fiedler & Lundgren AB.
In September 2024, Philip Morris International Inc. announces the sale of its subsidiary Vectura Group Ltd. (Vectura) to Molex Asia Holdings Ltd., and the establishment of master service agreements to develop Vectura Fertin Pharma's inhaled therapeutics proprietary pipeline. Vectura will be operated by Phillips Medisize, a Molex company.
In March 2024, Altria Group, Inc. announced that it has agreed to sell 35 million shares of Anheuser-Busch InBev SA/NV through a global secondary offering (offering) comprised of a public offering of ABI ordinary shares represented by American depositary shares (ADS) in the United States, a public offering of ABI ordinary shares in the United States, a concurrent private placement of ABI ordinary shares in the European Economic Area.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.